PPIDT00216

Drug Information
NameBivatuzumab
SequenceNot Available
DrugBank_IDDB06550
Typebiotech
IndicationInvestigated for use/treatment in cancer/tumors (unspecified) and head and neck cancer.

Dosage Forms
Form Route Strength
No dosage records.
Target Information
Role Uniprot_ID Gene_Name Entity_Name Organism Actions Internal link
target P16070 CD44 CD44 antigen Homo sapiens unknown Link